Making anticoagulation safer.

Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology (2002) 1.82

Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med (2009) 11.49

Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation (2004) 4.45

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke (2009) 3.89

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 3.48

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA (2002) 2.94

National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology (2014) 2.08

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke (2008) 2.06

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med (2003) 2.04

Irbesartan in patients with atrial fibrillation. N Engl J Med (2011) 1.84

The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J (2012) 1.82

Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Lancet Neurol (2012) 1.76

Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66

Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Ann Intern Med (2011) 1.56

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation (2003) 1.52

Predictors of stroke in patients paced for sick sinus syndrome. J Am Coll Cardiol (2004) 1.52

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study. Arch Intern Med (2005) 1.42

Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials. Stroke (2012) 1.23

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal. Thromb Res (2004) 1.22

Antithrombotic therapy for atrial fibrillation. BMJ (2002) 1.22

Leave 'em alone - why continuous variables should be analyzed as such. Neuroepidemiology (2008) 1.21

Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Stroke (2005) 1.20

Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol (2012) 1.16

High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke (2007) 1.14

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation (2002) 1.13

Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study. Blood Press Monit (2007) 1.12

Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J (2013) 1.12

Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. Stroke (2006) 1.11

ABC of antithrombotic therapy: Antithrombotic therapy for cerebrovascular disorders. BMJ (2002) 1.10

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med (2007) 1.08

Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants. Can J Cardiol (2013) 1.05

Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease. J Stroke Cerebrovasc Dis (2012) 1.05

Aspirin therapy and risk of subdural hematoma: meta-analysis of randomized clinical trials. J Stroke Cerebrovasc Dis (2013) 0.95

Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. Int J Stroke (2014) 0.91

Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial. Stroke (2012) 0.88

Headache improvement through TMD stabilization appliance and self-management therapies. Cranio (2006) 0.87

Thrombolysis for acute stroke in hemodialysis: international survey of expert opinion. Clin J Am Soc Nephrol (2011) 0.85

Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation. J Am Coll Cardiol (2013) 0.84

Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke (2012) 0.84

Anticoagulant therapy in acute brain ischaemia. Lancet Neurol (2013) 0.83

Sex, stroke, and atrial fibrillation. Arch Neurol (2012) 0.82

Neurologic manifestations of cardiogenic embolism: an update. Neurol Clin (2002) 0.80

Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study. J Hypertens (2012) 0.80

Late-developing cerebral arteropathy after pyogenic meningitis. Arch Neurol (2003) 0.80

Anticoagulants in patients with atrial fibrillation and end-stage renal disease. Postgrad Med (2012) 0.80

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants. Cardiol Ther (2013) 0.79

Do current guidelines result in overuse of warfarin anticoagulation in patients with atrial fibrillation? Ann Intern Med (2009) 0.77

Clinical research in primary stroke prevention: needs, opportunities, and challenges. Neuroepidemiology (2005) 0.77

Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves. Am J Hematol (2012) 0.76

Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials. Int J Stroke (2013) 0.76

Stroke prevention in asymptomatic carotid artery disease: revascularization of carotid stenosis is not the solution. Pol Arch Med Wewn (2015) 0.75

Why is WASID an important clinical trial? Neuroepidemiology (2003) 0.75

Stroke prevention in older adults with atrial fibrillation. CMAJ (2013) 0.75

Do we really need a better way to give heparin in acute cerebral ischemia? Stroke (2002) 0.75

Regarding article "Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". Stroke (2010) 0.75

Carotid-artery stenting versus endarterectomy. N Engl J Med (2005) 0.75

Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2003) 0.75

Anticoagulation intensity and stroke during warfarin-use in atrial fibrillation patients. Stroke (2006) 0.75

Data and safety monitoring in clinical research: a National Institute of Neurologic Disorders and Stroke perspective. Ann Emerg Med (2005) 0.75

Did we really need another comparison of warfarin with aspirin? An assessment of the BAFTA trial. Pol Arch Med Wewn (2007) 0.75

Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in. Card Electrophysiol Rev (2003) 0.75

Budgets for clinical trials. Front Neurol Neurosci (2009) 0.75

What's new in stroke? The top 10 studies of 2009-2011: part I. Pol Arch Med Wewn (2011) 0.75

What's new in stroke? The top 10 for 2004/05. J Am Geriatr Soc (2006) 0.75